Showing results (671-680 of 797) with videos related to
Sort By:
Pageof 80
Nature Medicine|January 18, 2022
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variantYu Gao, Curtis Cai, Alba Grifoni, et al.Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Mpox vaccine and infection-driven human immune signaturesHallie Cohn, Nathaniel Bloom, Gianna Cai, et al.Vaccines|August 29, 2024
Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVacDiego A Díaz-Dinamarca, Simone Cárdenas-Cáceres, Nicolás A Muena, et al.Cell Host & Microbe|May 26, 2023
Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpoxSarah Adamo, Yu Gao, Takuya Sekine, et al.Journal of Clinical Medicine|September 14, 2024
Ranolazine Unveiled: Rediscovering an Old Solution in a New LightGiulia Azzurra De Santis, Tommaso De Ferrari, Francesca Parisi, et al.European Journal of Cancer (Oxford, England : 1990)|May 31, 2022
The national COVID-19 vaccination campaign targeting the extremely vulnerable: the Florence Medical Oncology Unit experience in patients with cancerMaria S Pino, Simone Cheli, Marco Perna, et al.Science Immunology|December 8, 2023
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19Curtis Cai, Yu Gao, Sarah Adamo, et al.Emerging Infectious Diseases|October 5, 2017
Fatal Outbreak in Tonkean Macaques Caused by Possibly Novel Orthopoxvirus, Italy, January 2015 1Giusy Cardeti, Cesare Ernesto Maria Gruber, Claudia Eleni, et al.Science Immunology|June 28, 2020
Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndromeDaniela Weiskopf, Katharina S Schmitz, Matthijs P Raadsen, et al.JCI Insight|September 4, 2025
Pediatric T cell and B cell responses to SARS-CoV-2 infectionL Benjamin Hills, Numana Bhat, Jillian H Hurst, et al.Pageof 80